Fraser Murray
Chief Executive Officer at Pheno Therapeutics Ltd.
Fraser Murray active positions
| Companies | Position | Start | End |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Corporate Officer/Principal | 2021-12-31 | - |
| Pandeia Therapeutics Ltd. | Director/Board Member | 2018-12-31 | - |
| Chief Executive Officer | 2018-12-31 | - | |
| Founder | 2018-12-31 | - | |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | 2021-12-31 | - |
| Chief Executive Officer | 2022-10-31 | - | |
Tridek-One Therapeutics SAS
 Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Director/Board Member | - | - |
Career history of Fraser Murray
Training of Fraser Murray
| University of Strathclyde | Undergraduate Degree |
| The School of Pharmacy University of London | Doctorate Degree |
| Alliance Manchester Business School | Masters Business Admin |
Statistics
International
| United Kingdom | 7 |
| France | 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| Founder | 2 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
| Pandeia Therapeutics Ltd. | |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Tridek-One Therapeutics SAS
Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Commercial Services |
- Stock Market
- Insiders
- Fraser Murray
- Experience
